Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 18998-18999 [2013-07123]
Download as PDF
<![CDATA[
18998
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07124 Filed 3–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the contact person listed below in
advance of the meeting.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Diet, Obesity, and
Weight Change in Pregnancy: Biobehavioral
Influences and Intervention Approaches.
Date: April 25, 2013.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To provide concept review of
proposed concept review.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852.
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
Executive Boulevard, Rockville, MD 20892–
9304, (301) 435–6680,
skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; ZHD1 DSR–H MR 1.
Date: April 23, 2013.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Marita R. Hopmann, Ph.D.,
Scientific Review Officer, Division Of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5b01, Bethesda, MD 20892, 301–
435–6911, hopmannm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07126 Filed 3–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
[FR Doc. 2013–07127 Filed 3–27–13; 8:45 am]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
BILLING CODE 4140–01–P
VerDate Mar<15>2010
20:20 Mar 27, 2013
Jkt 229001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, ZHD1 DRG (RL).
Date: April 12, 2013.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health, 6100
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sherry L. Dupere, Ph.D.,
Director, Division Of Scientific Review,
Division Of Scientific Review, Eunice
Kennedy Shriver National Institute of Child
Health And Human Development, NIH, 6100
Executive Blvd., Room 5b01, Bethesda, MD
20892, 301–451–3415, duperes@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07121 Filed 3–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
E:\FR\FM\28MRN1.SGM
28MRN1
Federal Register / Vol. 78, No. 60 / Thursday, March 28, 2013 / Notices
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Loan Repayment
Program.
Date: April 22, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Officer, Division Of
Scientific Review, National Institute Of Child
Health And Human Development, 6100
Executive Boulevard, Rockville, Md 20892–
9304, (301) 435–6680,
skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–07123 Filed 3–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Start-Up
Exclusive License: Photosensitizing
Antibody-Fluorophore Conjugates for
Photoimmunotherapy
National Institutes of Health,
Public Health Service, HHS.
AGENCY:
mstockstill on DSK4VPTVN1PROD with NOTICES
ACTION:
Notice.
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(i), that the National
Institutes of Health (NIH), Department
of Health and Human Services (HHS), is
contemplating the grant of a worldwide
exclusive patent license, to practice the
inventions embodied in PCT patent
application PCT/US2012/044421, filed
June 27, 2012 (HHS Reference# E–205–
2010/2–PCT–01), which is a
continuation-in-part of U.S. Application
No. 13/180,111 (E–205–2010/1–US–01)
which claims priority to U.S.
provisional application No. 61/363,079
(E–205–2010/0–US–01), and entitled
‘‘Photosensitizing AntibodyFluorophore Conjugates,’’ to Aspyrian
Therapeutics, Inc., a company
incorporated under the laws of the State
VerDate Mar<15>2010
20:20 Mar 27, 2013
Jkt 229001
of Delaware, having its headquarters in
San Diego, California.
The United States of America is the
assignee of the rights of the above
invention.
The field of use may be limited to
‘‘use of photosensitizing antibodyfluorophore conjugate by itself for
Photoimmunotherapy (PIT), or in
combination with cancer therapeutic
agents, to treat cancer or pre-cancerous
hyperplasia’’, and may be further
limited to certain types of cancer and/
or specific platforms.
The license will include the priority
case US 13/180,111, which is currently
licensed to Aspyrian under an exclusive
evaluation option license. The exclusive
commercialization license proposed in
this notice will supersede and replace
the exclusive evaluation option license.
DATES: Only written comments and/or
applications for a license received by
the NIH Office of Technology Transfer
on or before April 12, 2013 will be
considered.
ADDRESSES: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Uri Reichman, Ph.D., M.B.A, Office
of Technology Transfer, National
Institutes of Health, 6011 Executive
Boulevard, Suite 325, Rockville, MD
20852–3804; Telephone: (301) 435–
4616; Facsimile: (301) 402–0220; Email:
Reichmau@mail.nih.gov. A signed
confidentiality nondisclosure agreement
will be required to receive copies of any
patent applications that have not been
published or issued by the United States
Patent and Trademark Office or the
World Intellectual Property
Organization.
SUPPLEMENTARY INFORMATION: The
invention is in the field of
Photoimmunotherapy (PIT). More
specifically, the invention relates to
antibody-fluorophore conjugates where
the antibody is specific for cancer cells
and the fluorophore is IR700 dye.
Binding of such conjugates to targeted
cancer cells followed by irradiation with
near infrared light (NIR) was shown to
kill cancer cells in a highly specific
manner. Furthermore, the invention
discloses that the therapeutic effect of
the PIT conjugate is significantly
enhanced by the administration of one
or more anti-cancer agents following the
irradiation step. This is achieved by the
markedly rapid accumulation of the
therapeutic agent in the PIT-treated
tissue. Also provided in the invention
are wearable devices that incorporate
NIR light emitting diodes (LEDs) and
can be used to activate the PIT
conjugates.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
18999
The prospective exclusive license will
comply with the terms and conditions
of 35 U.S.C. 209 and 37 CFR 404.7. The
prospective exclusive license may be
granted unless, within fifteen (15) days
from the date of this published notice,
NIH receives written evidence and
argument that establishes that the grant
of the license would not be consistent
with the requirements of 35 U.S.C. 209
and 37 CFR 404.7.
Properly filed competing applications
for a license filed in response to this
notice will be treated as objections to
the contemplated license. Comments
and objections submitted in response to
this notice will not be made available
for public inspection, and, to the extent
permitted by law, will not be released
under the Freedom of Information Act,
5 U.S.C. 552.
Dated: March 22, 2013.
Richard U. Rodriguez,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 2013–07166 Filed 3–27–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation and Approval of SGS
North America, Inc., as a Commercial
Gauger and Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation and
approval of SGS North America, Inc., as
a commercial gauger and laboratory.
AGENCY:
SUMMARY: Notice is hereby given,
pursuant to CBP regulations, that SGS
North America, Inc., has been approved
to gauge and accredited to test
petroleum and petroleum products,
organic chemicals and vegetable oils for
customs purposes for the next three
years as of November 1, 2012.
DATES: Effective Dates: The
accreditation and approval of SGS North
America, Inc., as commercial gauger and
laboratory became effective on
November 1, 2012. The next triennial
inspection date will be scheduled for
November 2015.
FOR FURTHER INFORMATION CONTACT:
Approved Gauger and Accredited
Laboratories Manager, Laboratories and
Scientific Services, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW., Suite 1500N, Washington,
DC 20229, tel. 202–344–1060.
E:\FR\FM\28MRN1.SGM
28MRN1
]]>Agencies
[Federal Register Volume 78, Number 60 (Thursday, March 28, 2013)]
[Notices]
[Pages 18998-18999]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-07123]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract
[[Page 18999]]
proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, Loan Repayment Program.
Date: April 22, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6100 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Sathasiva B. Kandasamy, Ph.D., Scientific Review
Officer, Division Of Scientific Review, National Institute Of Child
Health And Human Development, 6100 Executive Boulevard, Rockville,
Md 20892-9304, (301) 435-6680, skandasa@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 22, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-07123 Filed 3-27-13; 8:45 am]
BILLING CODE 4140-01-P
